Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of Diagnostic and Prognostic Model of Acute Coronary Syndrome Caused by Plaque Erosion Using Novel Serum Biomarkers

NCT06763835 is registered in ClinicalTrials.gov with Xuebo Liu as lead sponsor.

NCT NCT06763835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06763835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of Diagnostic and Prognostic Model of Acute Coronary Syndrome Caused by Plaque Erosion Using Novel Serum Biomarkers
Lead sponsor
Xuebo Liu
Phase
Observational
Overall status
Active, not recruiting
Start date
February 1, 2023
Completion date
July 30, 2026
Enrollment
301 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, plaque rupture